Chieko Muto

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

Daiki Mori, Emi Kimoto, Brian Rago et al. · Clinical Pharmacology & Therapeutics · 2019 · 101 citations · Full text

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

Hirotaka Nagashima, Miyako Suzuki, S Araki et al. · Osteoarthritis and Cartilage · 2011 · 79 citations

Rheumatoid Disorder, Rheumatology, Chronic Musculoskeletal Condition +7

Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers

Takeshi Miyake, Emi Kimoto, Lina Luo et al. · Clinical Pharmacology & Therapeutics · 2020 · 45 citations · Full text

Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment

Elena Soto, Satoshi Shoji, Chieko Muto et al. · British Journal of Clinical Pharmacology · 2013 · 43 citations · Full text

Population Pharmacokinetic Analysis of Voriconazole from a Pharmacokinetic Study with Immunocompromised Japanese Pediatric Subjects

Chieko Muto, Satoshi Shoji, Yoshiro Tomono et al. · Antimicrobial Agents and Chemotherapy · 2015 · 31 citations · Full text